Cellula Therapeutics

Lausanne, Switzerland · Founded 2023 · Privately Held (backing)

Developer of next-generation CAR-T cell therapies designed to cure solid tumours, specifically targeting aggressive brain cancers. Cellula Therapeutics is based in Lausanne, Switzerland and was founded in 2023. Its last reported valuation was $13.9 million in Jul 2025. It has raised $3.6 million.

Last reported valuation

$13.9M

Oct 2026

Priced at

—

Total raised

$3.6M

Last round

—

How much has Cellula Therapeutics raised?

$3.6Macross 0 recorded rounds

Private Market View

More of Cellula Therapeutics with a free Private Market View account

·Watch Cellula Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Cellula Therapeutics investors

2 investors are on record for Cellula Therapeutics, including Remora Biotech and University of Geneva.

For fundraisers

Raising for a company like Cellula Therapeutics?

2 investors have backed Cellula Therapeutics.

See all 2 investors →

Frequently asked about Cellula Therapeutics

How much has Cellula Therapeutics raised?: Cellula Therapeutics has raised $3.6M in total across 0 recorded funding rounds.